peptid pt141 PT-141 (Bremelanotide) PT 141: Peptide treatment for

Store both medications according to manufacturer guidelines

Skin Appendage Disorders, 3 (3), 166-169

Mild redness and swelling is normal and resolves within 2448 hours

The following assays are SET-based methods: Total phenolics assay using FolinCiocalteu reagent Trolox equivalent antioxidant capacity assay (TEAC) Ferric ion reducing antioxidant power assay (FRAP) Total antioxidant potential assay using a Cu 2+ complex as an oxidant 2,2-Diphenyl-1-picrylhydrazyl radical scavenging assay (DPPH) 2,2-Azinobis 3-ethylbenzthiazoline-6-sulfonic acid radical scavenging assay (ABTS + ) N,N-Dimethyl-p-phenylenediamine radical scavenging assay (DMPD + ) Cupric ion (Cu 2+ ) reducing antioxidant power assay (CUPRAC) It has been reported that ABTS methods involve both HAT and SET mechanisms (Prior et al